2021 ACR/VF 结节性多动脉炎管理指南
该指南针对系统性、非乙型肝炎相关结节性多动脉炎(PAN)提出16条推荐和1条未分级立场声明。推荐支持对重型PAN早期使用环磷酰胺联合糖皮质激素,通过减少两者长期暴露来限制毒性,并推荐影像学和组织活检用于诊断。多数推荐因证据不足被定为有条件推荐。
要点
- 重型PAN应早期使用环磷酰胺联合糖皮质激素治疗
- 通过减少环磷酰胺和糖皮质激素的长期暴露以限制毒性
- 影像学和组织活检用于PAN的诊断
核心结论
- 指南为PAN的诊断策略、药物使用和影像学检查提供指导。
- 推荐支持早期治疗重型PAN并限制治疗毒性。
研究设计与样本
- 由美国风湿病学会(ACR)和血管炎基金会(VF)制定,基于PICO格式的21个临床问题开展系统文献综述,采用GRADE方法评估证据质量并形成推荐,每条推荐需投票小组≥70%共识。
主要发现
- 共提出16条推荐和1条未分级立场声明。
- 多数推荐因证据匮乏被定为有条件推荐。
- 推荐支持对重型PAN早期使用环磷酰胺和糖皮质激素。
- 推荐通过最小化长期暴露来限制环磷酰胺和糖皮质激素的毒性。
- 推荐使用影像学和组织活检进行疾病诊断。
关键数值与推荐
- 每条推荐要求投票小组≥70%共识。
- 推荐支持早期使用环磷酰胺和糖皮质激素治疗重型PAN。
- 推荐限制环磷酰胺和糖皮质激素的长期暴露。
- 推荐使用影像学和组织活检用于诊断。
临床怎么用
- 对系统性、非乙型肝炎相关PAN,应早期识别重型病例并启动环磷酰胺联合糖皮质激素治疗。
- 治疗中应通过减少环磷酰胺和糖皮质激素的长期暴露来限制毒性。
- 诊断时可借助影像学和组织活检。
局限性
- 多数推荐因证据匮乏被定为有条件推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide evidence-based recommendations and expert guidance for the management of systemic polyarteritis nodosa (PAN). METHODS: Twenty-one clinical questions regarding diagnostic testing, treatment, and management were developed in the population, intervention, comparator, and outcome (PICO) format for systemic, non-hepatitis B-related PAN. Systematic literature reviews were conducted for each PICO question. The Grading of Recommendations Assessment, Development and Evaluation methodology was used to assess the quality of evidence and formulate recommendations. Each recommendation required ≥70% consensus among the Voting Panel. RESULTS: We present 16 recommendations and 1 ungraded position statement for PAN. Most recommendations were graded as conditional due to the paucity of evidence. These recommendations support early treatment of severe PAN with cyclophosphamide and glucocorticoids, limiting toxicity through minimizing long-term exposure to both treatments, and the use of imaging and tissue biopsy for disease diagnosis. These recommendations endorse minimizing risk to the patient by using established therapy at disease onset and identify new areas where adjunctive therapy may be warranted. CONCLUSION: These recommendations provide guidance regarding diagnostic strategies, use of pharmacologic agents, and imaging for patients with PAN.
引用
- Chung SA, Gorelik M, Langford CA, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa. Arthritis Rheumatol. 2021. PMID: 34235883. doi:10.1002/art.41776
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。